A significantly higher percentage of GC patients with stage III & IV disease were having elevated PDL1 mRNA levels compared to GC patients having stage I & II disease (71.9 vs. 25.4%; OR = 7.5; p = 0.00). The gene discussed is CD274; the disease is gastric cancer.